Woburn, Massachusetts-based Curamir Therapeutics, a biotech firm, has secured $10 million in Series A funding. The investor was Delos Capital.
Source: Press Release
Woburn, Massachusetts-based Curamir Therapeutics, a biotech firm, has secured $10 million in Series A funding. The investor was Delos Capital.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination